Kute, Vivek B.; Ramesh, Vasanthi; Rela, Mohamed
doi : 10.1097/TP.0000000000003677
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1625-1630
Organ transplantation in India to date relies predominantly (80.3%) on living donor procedures for kidney and liver transplantation. Heart, lung, pancreas, and small bowel transplants are therefore less frequent.1-4 There is also a pronounced gender inequality with a majority of male transplant recipients (81%), whereas most donors (78%) are female. At this time, there are limited living donor follow-up and variable recipient results. Most transplants take place in private sector hospitals with costs that nearly twice compared with those in the public sector.
Divyaveer, Smita; Nagral, Sanjay; Prasad, K.T.; Sharma, Ashish; Jha, Vivekanand
doi : 10.1097/TP.0000000000003685
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1631-1634
Kempkes, Rosalie W.M.; Issa, Fadi
doi : 10.1097/TP.0000000000003874
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1635-1636
Nellore, Anoma; Porrett, Paige M.
doi : 10.1097/TP.0000000000003727
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1637-1638
doi : 10.1097/TP.0000000000003807
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1639-1642
Quintini, Cristiano; Muiesan, Paolo; Detry, Olivier; Gastaca, Mikel; de Jonge, Jeroen; Clavien, Pierre-Alain; Del Prete, Luca; Fondevila, Constantino
doi : 10.1097/TP.0000000000003877
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1643-1652
Cook, Charles H.
doi : 10.1097/TP.0000000000003549
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1653-1654
Weinberg, Laurence; Collins, Michael G.; Peyton, Philip
doi : 10.1097/TP.0000000000003582
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1655-1657
Peters, Anna L.; Tremblay, Simon; Alloway, Rita R.; Woodle, E. Steve
doi : 10.1097/TP.0000000000003418
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1658-1659
Schinstock, Carrie A.
doi : 10.1097/TP.0000000000003497
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1660-1661
Tedla, Fasika M.; Sanchez Russo, Luis; Menon, Madhav C.
doi : 10.1097/TP.0000000000003479
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1662-1663
van Heeswijk, Ruud B.; Hullin, Roger
doi : 10.1097/TP.0000000000003420
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1664-1665
Cunningham, Kyle T.; Mills, Kingston H.G.
doi : 10.1097/TP.0000000000003673
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1666-1676
Wagener, Gebhard; Bezinover, Dmitri; Wang, Cynthia; Kroepfl, Elizabeth; Diaz, Geraldine; Giordano, Chris; West, James; Kindscher, James D.; Moguilevitch, Marina; Nicolau-Raducu, Ramona; Planinsic, Raymond M.; Rosenfeld, David M.; Lindberg, Scott; Schumann, Roman; Pivalizza, Evan G.
doi : 10.1097/TP.0000000000003581
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1677-1684
Parajuli, Sandesh; Aziz, Fahad; Garg, Neetika; Wallschlaeger, Rebecca E.; Lorden, Heather M.; Al-Qaoud, Talal; Mandelbrot, Didier A.; Odorico, and Jon S.
doi : 10.1097/TP.0000000000003586
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1685-1694
There are a variety of definitions and criteria used in clinical practice to define frailty. In the absence of a gold-standard definition, frailty has been operationally defined as meeting 3 out of 5 phenotypic criteria indicating compromised function: low grip strength, low energy, slowed walking speed, low physical activity, and unintentional weight loss. Frailty is a common problem in solid organ transplant candidates who are in the process of being listed for a transplant, as well as after transplantation.
Jones, Benjamin P.; Kasaven, Lorraine; Vali, Saaliha; Saso, Srdjan; Jalmbrant, Maria; Bracewell-Milnes, Timothy; Thum, Meen-Yau; Quiroga, Isabel; Friend, Peter; Diaz-Garcia, Cesar; Ghaem-Maghami, Sadaf; Yazbek, Joseph; Lees, Christoph; Testa, Giuliano; Johannesson, Liza; Jones, Bryony; Smith, J. Richard
doi : 10.1097/TP.0000000000003578
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1695-1707
Uterine transplantation (UTx) is a fertility restoring treatment for women with absolute uterine factor infertility. At a time when there is no question of the procedure’s feasibility, and as the number of livebirths begins to increase exponentially, various important reproductive, fetal, and maternal medicine implications have emerged.
Budhiraja, Pooja; Kalot, Mohamad A.; Alayli, Abdallah El; Dimassi, Ahmad; Kaplan, Bruce; Chakkera, Harini A.; Mustafa, Reem A.
doi : 10.1097/TP.0000000000003503
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1708-1717
Participant withdrawal from clinical trials occurs for various reasons, predominantly adverse effects or intervention inefficacy. Because these missing participant data can have implications for the validity, reproducibility, and generalizability of study results, when conducting a systematic review, it is important to collect and appropriately analyze missing data information to assess its effects on the robustness of the study results.
Saunders, Ute; Li, Mao; Boddeda, Srinivasa R.; Maher, Sonya; Ghere, Jessica; Kaptsan, Irina; Dhital, Ravi; Velazquez, Victoria; Guo, Lingling; Chen, Bo; Zeng, Qiang; Schoeb, Trenton R.; Cianciolo, Rachel; Shimamura, Masako
doi : 10.1097/TP.0000000000003548
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1718-1729
Human cytomegalovirus (CMV) infection is associated with renal allograft dysfunction and loss, particularly in combination with acute rejection. Emerging literature suggests that non-HLA antibodies may contribute to antibody-mediated rejection, but pathogen-induced antibodies have not been investigated in this context. This study examines the presence of CMV-induced antibodies in murine CMV (MCMV)–infected renal allografts during acute rejection.
Bascom, Roger A.; Tao, KeSheng; West, Lori J.
doi : 10.1097/TP.0000000000003566
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1730-1746
In Medawar’s murine neonatal tolerance model, injection of adult semiallogeneic lymphohematopoietic cells (spleen cells [SC] and bone marrow cells [BMC]) tolerizes the neonatal immune system. An eventual clinical application would require fully allogeneic (allo) cells, yet little is known about the complex in vivo/in situ interplay between those cells and the nonconditioned neonatal immune system.
Olariu, Radu; Tsai, Catherine; Abd El Hafez, Mai; Milusev, Anastasia; Banz, Yara; Lese, Ioana; Leckenby, Jonathan I.; Constantinescu, Mihai; Rieben, Robert; V?gelin, Esther; Taddeo, Adriano
doi : 10.1097/TP.0000000000003601
Transplantation: August 2021 - Volume 105 - Issue 8 - p 1747-1759
The lymphatic system plays an active role in modulating inflammation in autoimmune diseases and organ rejection. In this work, we hypothesized that the transfer of donor lymph node (LN) might be used to promote lymphangiogenesis and influence rejection in vascularized composite allotransplantation (VCA).
Vallant, Natalie; Wolfhagen, Nienke; Sandhu, Bynvant; Hamaoui, Karim; Cook, Terence; Pusey, Charles; Papalois, Vassilios
doi : 10.1097/TP.0000000000003599
Transplantation. 105(8):1760-1770, August 2021
Hypothermic machine perfusion (HMP) is a well-established method for deceased donor kidney preservation. Normothermic machine perfusion (NMP) might offer similar or greater advantages. We compared the 2 methods in an ex vivo perfusion model using 34 porcine kidneys.
Nguyen-Buckley, Christine; Gao, Wei; Agopian, Vatche; Wray, Christopher; Steadman, Randolph H.; Xia, Victor W.
doi : 10.1097/TP.0000000000003427
Transplantation. 105(8):1771-1777, August 2021
Although hemorrhage is a major concern during liver transplantation (LT), the risk for thromboembolism is well recognized. Implementation of rotational thromboelastometry (ROTEM) has been associated with the increased use of cryoprecipitate; however, the role of ROTEM-guided transfusion strategy and cryoprecipitate administration in the development of major thromboembolic complications (MTCs) has never been documented.
El-domiaty, Nada; Saliba, Faouzi; Vibert, Eric; Karam, Vincent; Sobesky, Rodolphe; Ibrahim, Wafaa; Pittau, Gabriella; Ciacio, Oriana; Salloum, Chady; Amer, Khaled; Saeed, Maysaa A.; Shawky, Jihan A.; Sa Cunha, Antonio; Rosmorduc, Olivier; Cherqui, Daniel; Adam, René; Samuel, Didier
doi : 10.1097/TP.0000000000003434
Transplantation. 105(8):1778-1790, August 2021
Hepatocellular carcinoma (HCC) is currently the first indication of liver transplantation (LT) in Europe and Asia-Pacific region and the third in the United States. HCC recurrence is the main complication affecting short- and medium-term outcomes after LT.
Rhu, Jinsoo; Kim, Mi Seung; Choi, Gyu-Seong; Jeong, Woo Kyoung; Kim, Jong Man; Joh, Jae-Won
doi : 10.1097/TP.0000000000003423
Transplantation. 105(8):1791-1799, August 2021
This study was designed to analyze the clinical impact of a new bile duct division technique during laparoscopic living donor hepatectomy.
Mezochow, Alyssa K.; Abt, Peter L.; Bittermann, Therese
doi : 10.1097/TP.0000000000003417
Transplantation. 105(8):1800-1807, August 2021
There is no unified consensus as to the preferred immunosuppression (IS) strategy following liver retransplantation (reLT).
Jordan, Stanley C.; Legendre, Christophe; Desai, Niraj M.; Lorant, Tomas; Bengtsson, Mats; Lonze, Bonnie E.; Vo, Ashley A.; Runstr?m, Anna; Laxmyr, Lena; Sj?holm, Kristoffer; Schi?tt, ?sa; Sonesson, Elisabeth; Wood, Kathryn; Winstedt, Lena; Kjellman, Christian; Montgomery, Robert A.
doi : 10.1097/TP.0000000000003496
Transplantation. 105(8):1808-1817, August 2021
Highly HLA sensitized patients have limited access to life-saving kidney transplantation because of a paucity of immunologically suitable donors. Imlifidase is a cysteine protease that cleaves IgG leading to a rapid decrease in antibody level and inhibition of IgG-mediated injury. This study investigates the efficacy and safety of imlifidase in converting a positive crossmatch test to negative, allowing highly sensitized patients to be transplanted with a living or deceased donor kidney
Sethi, Supreet; Peng, Alice; Najjar, Reiad; Vo, Ashley; Jordan, Stanley C.; Huang, Edmund
doi : 10.1097/TP.0000000000003512
Transplantation. 105(8):1818-1824, August 2021
Tocilizumab is an interleukin-6 receptor antagonist recently described as a promising treatment for antibody-mediated rejection. We compared infectious complications among tocilizumab-treated kidney transplant patients with those receiving intravenous immunoglobulin (IVIG)/rituximab.
Luan, Danny; Dadhania, Darshana M.; Ding, Ruchuang; Muthukumar, Thangamani; Lubetzky, Michelle; Lee, John R.; Sharma, Vijay K.; August, Phyllis; Mueller, Franco B.; Schwartz, Joseph E.; Suthanthiran, Manikkam
doi : 10.1097/TP.0000000000003478
Transplantation. 105(8):1825-1839, August 2021
T cell–mediated rejection (TCMR) is the most frequent type of acute rejection and is associated with kidney allograft failure. Almost 40% of TCMR episodes are nonresponsive to therapy, and molecular mechanisms for the nonresponsiveness are unknown. Our single-center study identified that urinary cell FOXP3 mRNA abundance predicts TCMR reversibility and allograft survival.
Lentine, Krista L.; Cheungpasitporn, Wisit; Xiao, Huiling; McAdams-DeMarco, Mara; Lam, Ngan N.; Segev, Dorry L.; Bae, Sunjae; Ahn, JiYoon B.; Hess, Gregory P.; Caliskan, Yasar; Randall, Henry B.; Kasiske, Bertram L.; Schnitzler, Mark A.; Axelrod, David A.
doi : 10.1097/TP.0000000000003547
Transplantation. 105(8):1840-1849, August 2021
Although the population of older transplant recipients has increased dramatically, there are limited data describing the impact of immunosuppression regimen choice on outcomes in this recipient group.
Nguyen, Tiffany; Sise, Meghan E.; Delgado, Cindy; Williams, Winfred; Reese, Peter; Goldberg, David
doi : 10.1097/TP.0000000000003511
Transplantation. 105(8):1850-1857, August 2021
Transplantation of kidneys from hepatitis C virus (HCV)-viremic donors into HCV-negative patients followed by direct-acting antiviral therapy was an important breakthrough to increase the number of life-saving kidney transplants. Data suggest that these transplants offer several benefits; however, it is unknown whether adoption of this practice has been shared equitably, especially among disadvantaged groups.
Barba, Thomas; Bachy, Emmanuel; Maarek, Alizée; Fossard, Gaëlle; Genestier, Laurent; Anglicheau, Dany; Moal, Valérie; Dantal, Jacques; Rieu, Philippe; Chemouny, Jonathan; Charrier, Manon; Durrbach, Antoine; Provot, François; Ducloux, Didier; Westeel, Pierre-François; Heng, Anne-Elisabeth; Rerolle, Jean-Philippe; Barrou, Benoit; Grimbert, Philippe; Chatelet, Valérie; Mousson, Christiane; Janbon, Bénédicte; Pernin, Vincent; Frimat, Luc; Ouali, Nacera; Glotz, Denis; Thierry, Antoine; Mariat, Christophe; Büchler, Mathias; Gaulard, Philippe; Leblond, Véronique; Morelon, Emmanuel; Dubois, Valérie; Salles, Gilles; Caillard, Sophie; Thaunat, Olivier
doi : 10.1097/TP.0000000000003568
Transplantation. 105(8):1858-1868, August 2021
Posttransplant lymphoproliferative disorders (PTLDs) encompass a spectrum of heterogeneous entities. Because the vast majority of cases PTLD arise from B cells, available data on PTLD of T or NK phenotype (T/NK-cell PTLD) are scarce, which limits the quality of the management of these patients.
Tchiloemba, Bianief; Kauke, Martin; Haug, Valentin; Abdulrazzak, Obada; Safi, Ali-Farid; Kollar, Branislav; Pomahac, Bohdan
doi : 10.1097/TP.0000000000003513
Transplantation. 105(8):1869-1880, August 2021
Facial vascularized composite allotransplantation (fVCA) represents a reconstructive approach that enables superior improvements in functional and esthetic restoration compared with conventional craniomaxillofacial reconstruction. Outcome reports of fVCA are usually limited to short-term follow-up or single-center experiences. We merge scientific literature on reported long-term outcome data to better define the risks and benefits of fVCA.
Obed, Aiman; Al Shaikh, Saeed; Bashir, Abdullah; Jarrad, Anwar
doi : 10.1097/TP.0000000000003749
Transplantation. 105(8):e79, August 2021
Midtvedt, Karsten; Tran, Trung; Parker, Krystina; Marti, Hans-Peter; Stenehjem, Aud-E.; G?ransson, Lasse Gunnar; M?rkve Soldal, Kari; Madsen, Camilla; Smedbr?ten, Julia; Vaage, Eline Benno; Lund-Johansen, Fridtjof; ?sberg, Anders
doi : 10.1097/TP.0000000000003856
Transplantation. 105(8):e80-e81, August 2021
Boyarsky, Brian J.; Chiang, Teresa P.-Y.; Ou, Michael T.; Werbel, William A.; Massie, Allan B.; Segev, Dorry L.; Garonzik-Wang, Jacqueline M.
doi : 10.1097/TP.0000000000003850
Transplantation. 105(8):e82-e83, August 2021
Jamme, Matthieu; Elalamy, Ismail; d’Izarny Gargas, Thibaut; Pettenati, Caroline; Desire, Eva; Tissot, Adrien; Rabant, Marion; Lefebvre, Mathilde; Soorojebally, Yanish; Vourc’h, Mickael; Conti, Filomena; Ferlicot, Sophie; Delahousse, Michel; Sartorius-Brodin, Albane; Hertig, Alexandre
doi : 10.1097/TP.0000000000003847
Transplantation. 105(8):e84-e86, August 2021
Connelly, Christopher R.; Quillin, Ralph Cutler; Biesterveld, Ben E.; Highet, Alexandra; Schenk, Austin D.; Syed, Shareef; Bongu, Advaith; Waits, Seth A.
doi : 10.1097/TP.0000000000003711
Transplantation. 105(8):e87-e88, August 2021
Mabrut, Jean-Yves; Lesurtel, Mickaël; Muller, Xavier; Dubois, Rémi; Ducerf, Christian; Rossignol, Guillaume; Mohkam, Kayvan
doi : 10.1097/TP.0000000000003775
Transplantation. 105(8):e89-e90, August 2021
Singh, Neeraj; Parsons, Ronald; Lentine, Krista; Woodside, Kenneth J.; Basu, Arpita; Cheungpasitporn, Wisit; Kensinger, Clark; Parajuli, Sandesh; Rivera, Franco H. Cabeza; Sultan, Samuel; Tantisattamo, Ekamol; Zibari, Gazi; Pavlakis, Martha; Cooper, Matthew
doi : 10.1097/TP.0000000000003752
Transplantation. 105(8):e91-e92, August 2021
Chadban, Steve J.; Knoll, Greg A.
doi : 10.1097/TP.0000000000003753
Transplantation. 105(8):e93, August 2021
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟